Pinealon is a synthetic tripeptide derived from the pineal gland that people run off-label for sleep quality, circadian rhythm regulation, and cognitive enhancement, with six of nine captured community reports citing sleep benefits and three citing cognitive improvements. Clinician sources converge on a daily protocol of 1 mg subcutaneously every morning, continuous, with no structured breaks or cycling. The honest tradeoff is that no FDA-approved indication exists, so all human use is off-label or compounded without the backing of human clinical trials.

Research Evidence
Evidence shape
No completed human trials extracted for Pinealon. Animal-model evidence carries the indication cards below.
Anecdotal efficacy
Side effects
Clinical research side effects
Clinical safety table not projected yet.
Anecdotal side effects
Price
price offers can be sorted by column
Dosing & Protocol
How Pinealon is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.
No structured protocol details captured for this tier yet.
Clinician protocols dose 1 mg daily subQ (2 sources).
No structured protocol details captured for this tier yet.
Peptide Deep Dive
Peptide Deep Dive is not projected for this peptide yet.
Peptide feedback
0 forum repliesLive community discussion for Pinealon, shown here in the site layout and continued on the TVR forum.
No peptide feedback yet
Start the peptide feedback thread on the TVR forum.